Michael Zelefsky, MD, FASTRO

NYU Langone Laura and Isaac Perlmutter Cancer Center

New York, NY

Disclosures:

Presentations

Oct 01

1116 - Discordance of Adverse Molecular Features between the 22-Gene Genomic Classifier Score, Histologic Grade, and NCCN Risk Groups: Analysis of Over 200,000 Patients

08:15am - 08:20am PT